Back to Authors

Dodick, David W.

https://orcid.org/0000-0002-9486-6790

A5057290642 | I1330342723

Mayo Clinic

Atria Academy of Science and Medicine, New York, NY, United States

Citations 387

Efficacy of Erenumab in Chronic Migraine Patients With and Without Allodynia (P2.10-025)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p2.10-025

Early and Sustained Effect of OnabotulinumtoxinA for Chronic Migraine Treatment: Pooled Analysis of PREEMPT Data (P2.10-018)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p2.10-018

Improved Functionality, Pain Relief, and Satisfaction in Patients Treated With Ubrogepant vs Placebo: Results from 2 Single-Attack Phase 3 Studies, ACHIEVE I and II (P2.10-012)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p2.10-012

Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication (P1.10-011)

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.p1.10-011

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (S26.002)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.s26.002

Effect of CGRP Inhibition with TEV-48125 on Cardiovascular Parameters as a Function of Triptan Use Among Individuals with Chronic Migraine (P2.205)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p2.205

Treatment of Medication-Overuse Headache: A Systematic Review (P2.203)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p2.203

Effect of CGRP Inhibition with TEV-48125 on Cardiovascular Parameters as a Function of Triptan Use Among Individuals with Chronic Migraine (I3.011)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i3.011

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i3.001

A Multicenter, Prospective, Single Arm, Open Label, Post-Market, Observational Study to evaluate the use of sTMS in reduction of Migraine Headache (ESPOUSE Study) (S52.004)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.s52.004